Titan Pharmaceuticals, Inc. (TTNP)
NASDAQ: TTNP · Real-Time Price · USD
3.790
+0.090 (2.43%)
Apr 24, 2025, 2:30 PM EDT - Market open

Titan Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
336111023
Upgrade
Market Cap Growth
-52.04%-52.04%-45.75%13.29%-56.58%109.11%
Upgrade
Enterprise Value
1-1-17325
Upgrade
Last Close Price
3.703.268.2515.6620.4065.80
Upgrade
PS Ratio
--33.7820.576.634.81
Upgrade
PB Ratio
1.391.220.948.401.976.59
Upgrade
P/TBV Ratio
1.391.220.948.401.976.59
Upgrade
EV/Sales Ratio
---12.971.985.08
Upgrade
Debt / Equity Ratio
--0.090.140.060.23
Upgrade
Asset Turnover
--0.030.090.190.55
Upgrade
Inventory Turnover
---23.8518.9714.34
Upgrade
Quick Ratio
5.995.994.711.132.301.49
Upgrade
Current Ratio
6.056.055.551.372.711.74
Upgrade
Return on Equity (ROE)
-103.63%-103.63%-139.14%-313.98%-202.44%-298.37%
Upgrade
Return on Assets (ROA)
-51.74%-51.74%-74.90%-106.15%-72.71%-52.18%
Upgrade
Return on Capital (ROIC)
-59.05%-59.05%-103.87%-183.11%-119.58%-89.95%
Upgrade
Earnings Yield
-138.75%-157.90%-89.61%-89.09%-86.78%-78.33%
Upgrade
FCF Yield
-114.39%-130.18%-114.15%-71.43%-78.34%-76.19%
Upgrade
Buyback Yield / Dilution
-19.55%-19.55%-11.91%-38.13%-157.89%-392.56%
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q